Defective Drug Class Actions
Patients rely on prescription and over-the-counter medications to treat illness, manage chronic conditions, and improve quality of life. Like medical devices, pharmaceutical drugs can generate substantial profits for manufacturers. These financial incentives may create pressure to rush products to market or minimize known or potential health risks and side effects.
In some cases, warning signs that emerge after a drug’s release may be overlooked, resulting in delayed safety warnings or recalls. When drugs are not adequately tested, labelled, or marketed, the consequences can be serious. Patients may suffer significant physical harm, pain, disability, and in some cases, death.
Our lawyers represent individuals and families whose lives have been negatively affected by defective or dangerous drugs. Our lawyers have pursued defective drug cases against major industry players such as Abbott, Bayer, Pfizer, Janssen-Ortho and Merck Frosst. We will fight for patients whose lives have been affected by:
- Defective or unsafe drug design;
- Insufficient testing for side effects, particularly serious risks such as heart attack, stroke, and significant psychiatric effects;
- Insufficient evidence supporting a drug’s effectiveness;
- Improper marketing or labelling; and
- Misrepresentation or falsification of clinical testing data.
In our work, we seek not only to compensate individuals who have been harmed, but also to promote safer practices across the pharmaceutical industry by deterring drug manufacturers from rushing to market or employing negligent marketing or labelling practices.
Frequently Asked Questions
Who may have a defective drug claim?
Individuals and families may have a claim when their lives have been negatively affected by defective or dangerous drugs.
What types of harm can result from defective drugs?
When drugs are not adequately tested, labelled, or marketed, patients may suffer significant physical harm, pain, disability, and in some cases, death.
Related Cases
-
Defective Drugs, Product Liability
Abilify
Abilify and Abilify Maintena are alleged to cause or materially increase the risk of compulsive behaviours, with inadequate warning to…
-
Defective Drugs, Product Liability
Actos
Actos (pioglitazone) is alleged to have materially increased the risk of bladder cancer in users, without adequate warning from its…
-
Consumer Class Actions, Defective Drugs
OxyContin
OxyContin and OxyNEO users allege they were not adequately warned about the risks of dependency and addiction, of which the…
-
Consumer Class Actions, Defective Drugs
Rexulti
Rexulti is alleged to be associated with impulse control disorders and compulsive behaviours, with inadequate warning to Canadian users.
-
Defective Drugs, Product Liability
Tylenol 3
Related News
Settlement Approved in the Canadian REXULTI® Class Action
Global News: Rochon Genova Launches National Class Action Over Rexulti Side Effects
Can I file a legal claim if my medication is ineffective?
Zelnorm Discontinuance
Merck Announces $4.85 Billion Vioxx Settlement
Pharmaceutical liability: Health Canada wants codeine off shelves
Class action litigation: OxyContin users waiting for compensation
Ontario pharmaceutical liability and the dark side of Tylenol 3
Oxy Settlement Agreement – Signed March-8-17
Hydroxycut recalled after injuries and one death
Why was the Vioxx settlement approved?
Breast-fed babies could be harmed by codeine
Lawsuit started for those who used Abilify and Abilify Maintena
Arthritis sufferers were given compensation for using Bextra
Antacid drugs associated with dementia in elderly patients
How pharmaceutical liability can get very complicated
Takeda Pharmaceuticals accused of deleting evidence
Apotex and Sandoz Implicated in Bladder Cancer Case
Update: (April 20, 2013): Canada-Wide Vioxx Settlement Agreement Approved
Update: The first of 3,000 actions relating to Actos goes to trial in the U.S.
Certification Record Filed in Class Action Commenced Against Diabetes Drug Manufacturers and Distributors: ACTOS Users Are at Heightened Risk of Developing Bladder Cancer
Recours collectif intenté contre les fabricants et distributeurs d’un médicament contre le diabète : un Québecois auquel ACTOS était prescrit est touché par le cancer de la vessie
Quebec Class Action Commenced Against Diabetes Drug Manufacturers and Distributors: Quebec Man Prescribed ACTOS Contracts Bladder Cancer
Canada-wide settlement reached in vioxx class actions – January 20, 2012
Class Action Commenced Against Diabetes Drug Manufacturers and Distributors: Toronto Woman Prescribed ACTOS Dies From Bladder Cancer
Oxycontin Class Action Update – October 21, 2010
Vioxx Class Action Update – December 23, 2009
Prepulsid Class Action Update – October 16, 2009
Canadian Hydroxycut Product Recall – May 5, 2009
Zelnorm Class Action – November 3, 2008
Study finds codeine harmful to some breast-fed babies
Canadian Serzone Class Action Settlement Approved
Oxycontin Class Action Commenced
Codeine/Morphine Class Action Lawsuit Commenced
Prepulsid Certified as Class Action
Ponderal and Redux National Class Action
Contact Rochon Genova
Call Rochon Genova at 416-363-1867 or send us an email to set up a free consultation.
